Ara A. Vaporciyan

Thoracic Surgery

210 Ashville Ave # 408
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 278 publications

Dual-degenerate TCRs target multiple KRAS hotspot and HLA-A3 family combinations.

Dual-degenerate TCRs target multiple KRAS hotspot and HLA-A3 family combinations.

Journal: Research square

Published: June 29, 2026

Using Induction Chemoimmunotherapy as a Bridge to Definitive Local Therapy for Non-Metastatic NSCLC: Real-World Outcomes From a Comprehensive Cancer Center.

Using Induction Chemoimmunotherapy as a Bridge to Definitive Local Therapy for Non-Metastatic NSCLC: Real-World Outcomes From a Comprehensive Cancer Center.

Journal: Clinical lung cancer

Published: June 05, 2026

CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer.

CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer.

Journal: medRxiv : the preprint server for health sciences

Published: May 04, 2026

Deep learning of CT imaging predicts PD-L1 expression and immunotherapy response in metastatic NSCLC: A multi-center study.

Deep learning of CT imaging predicts PD-L1 expression and immunotherapy response in metastatic NSCLC: A multi-center study.

Journal: Cancer letters

Published: March 04, 2026

Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trial.

Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trial.

Journal: International journal of radiation oncology, biology, physics

Published: December 02, 2025

Long-Term Outcomes After Proton Therapy Versus Intensity Modulated Photon Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Post Hoc Analysis of a Prospective Randomized Trial.

Long-Term Outcomes After Proton Therapy Versus Intensity Modulated Photon Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Post Hoc Analysis of a Prospective Randomized Trial.

Journal: International journal of radiation oncology, biology, physics

Published: December 02, 2025

Training left-handed cardiothoracic surgeons in a right-handed world: Perspectives, experiences, and educational opportunities.

Training left-handed cardiothoracic surgeons in a right-handed world: Perspectives, experiences, and educational opportunities.

Journal: JTCVS open

Published: November 10, 2025

Outcomes of Lobectomy vs Sublobar Resection for Clinical Stage IA3 Non-Small Cell Lung Cancer.

Outcomes of Lobectomy vs Sublobar Resection for Clinical Stage IA3 Non-Small Cell Lung Cancer.

Journal: The Annals of thoracic surgery

Published: November 09, 2025

Outcomes Of Neoadjuvant Chemoradiation Vs Neoadjuvant Chemotherapy for Esophageal Junction Signet Ring Cell Adenocarcinoma.

Outcomes Of Neoadjuvant Chemoradiation Vs Neoadjuvant Chemotherapy for Esophageal Junction Signet Ring Cell Adenocarcinoma.

Journal: The Annals of thoracic surgery

Published: November 09, 2025

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

Journal: Cancers

Published: October 24, 2025

Imaging predictors of pleural response in stage IV non-small cell lung cancer.

Imaging predictors of pleural response in stage IV non-small cell lung cancer.

Journal: JTCVS open

Published: September 25, 2025

Outcomes of Thoracic Surgical Oncology Group 103: Multimodality management in risk-stratified patients with lung-limited metastatic colorectal cancer.

Outcomes of Thoracic Surgical Oncology Group 103: Multimodality management in risk-stratified patients with lung-limited metastatic colorectal cancer.

Journal: JTCVS open

Published: September 23, 2025

Showing 1-12 of 278

Last Updated: 09/26/2026